Kratom products; modifying certain definitions. Effective date.
SB 183 amends the Oklahoma Kratom Consumer Protection Act by revising several statutory definitions that govern kratom products sold in the state. The bill defines “food,” “kratom leaf,” “kratom leaf extract,” “kratom product,” “total kratom alkaloids,” and “vendor,” and it updates the law’s reference to the controlling section of statute. It also sets technical standards for what qualifies as kratom leaf and kratom leaf extract, including limits on alkaloid content, allowable extraction solvents, and the composition of kratom products.
Under the bill, kratom leaf must be in fresh, dehydrated, or dried form with no post-harvest processing beyond drying or size reduction, and its total alkaloid content may not exceed 3.5% on a dried weight basis. Kratom leaf extract must be produced with specified solvents or other legally permitted food-ingredient solvents, and the extract must be mitragynine-dominant relative to other alkaloids. Kratom products may not contain synthesized kratom alkaloids, synthesized constituents, or synthesized metabolites, and the bill limits 7-hydroxymitragynine to no more than 1% of total kratom alkaloids as verified by HPLC testing.
The bill’s impact is primarily regulatory: it tightens and clarifies the definitions used to enforce Oklahoma’s kratom consumer protection framework. That affects manufacturers, wholesalers, retailers, food and beverage businesses, and other vendors that sell or handle kratom products, because compliance will depend on product composition, testing, and sourcing standards. The bill does not create a new licensing scheme or criminal penalty in the text provided, but it would shape what products may be marketed as kratom products under state law.
There is no recorded committee transcript or vote history in the materials provided, so the overall sentiment cannot be measured from debate or roll calls. Based on the bill text alone, the measure appears technical and consumer-protection oriented rather than controversial on its face, focusing on product purity and anti-adulteration standards. Because it was referred to the Health and Human Services Committee, the likely policy emphasis is public health and product safety.
No specific points of contention are documented in the available context. Potential areas of debate, however, would likely center on the scientific basis for the alkaloid thresholds, the feasibility and cost of HPLC testing, and whether the definitions are too restrictive for manufacturers or retailers. Another possible issue is whether the bill effectively distinguishes natural kratom products from synthetic or enhanced products in a way that is enforceable in the marketplace.
SB 183 would amend 63 O.S. Section 1-1432.2, the definitional section of the Oklahoma Kratom Consumer Protection Act, by tightening the statutory definitions that determine what counts as kratom leaf, kratom extract, kratom product, and vendor. These changes would affect how kratom products are manufactured, tested, labeled, sold, and regulated in Oklahoma, especially by limiting synthetic ingredients and setting alkaloid-content and extraction standards. The bill is effective November 1, 2025.
The available record shows no committee discussion or votes, so there is no direct evidence of support or opposition from legislative debate. The bill’s text suggests a generally cautious, consumer-protection approach focused on product safety, purity, and standardization. Because it is a definitional and technical amendment rather than a broader policy overhaul, it appears likely to have been treated as a regulatory housekeeping measure, though any opposition would likely come from industry stakeholders concerned about compliance burdens or product restrictions.
No explicit contention is documented in the provided materials. If debated, the most likely points of disagreement would be the strictness of the alkaloid limits, the prohibition on synthesized kratom components, the requirement for HPLC confirmation, and whether the definitions are too narrow for existing kratom manufacturers and vendors. Public health advocates would likely favor the tighter standards, while some sellers or processors could argue the rules are burdensome or difficult to meet.